Human Patient Simulator Assists Training Physicians In New Drug

October 21, 1998

A Penn State researcher has shown that a robotic patient simulator can be an effective stand-in to teach doctors how new drugs affect real patients.

W. Bosseau Murray, M.D. associate professor of anesthesiology in Penn State' College of Medicine, recently conducted physician training programs using a patient simulator and the relatively new drug, remifentanil, an anesthetic manufactured by Glaxo Wellcome. The drug was introduced in 1996 after FDA approval. Its effects are strong, fast acting and last only five to 10 minutes. The drug's side effects appear equally quickly.

"This is an excellent drug, but because it is so potent, this training was very valuable for the physicians," says Murray, also an anesthesiologist at Hershey Medical Center of the Penn State Geisinger Health System.

"If you have never seen these side effects, and if the heart rate slows, you would grab medication to speed the heart rate and then it would go too fast. You would have this seesaw between slow and fast and this would not be good for the patient. With this training, the physician can accept a drop in heart rate, knowing it will come back in a minute or two."

Murray was one of several instructors who taught physicians the proper way to use the drug. He reports that a human patient simulator helps train physicians as it reacts in real time just as a human patient would react. By using different scenarios, physicians can get experience just as if they were treating human beings.

He explains that a human patient simulator was transported to 58 cities across the U.S. in 1996 and 1997 so physicians could learn how to use the drug. A total of 836 anesthesiologists and residents participated. Nearly 80 percent had no prior experience with a full human patient simulator. Remifentanil was available at 36 percent of the participants' hospitals, available on a trial basis at 18 percent, under review in 19 percent, and not available at 23 percent of those surveyed.

"There was a significant difference in comfort level after the training session. Eighty-one percent said clinical simulation experience was an excellent way to learn about new drugs like remifentanil, " says Murray.

The Penn State researcher, who coordinates a simulation lab at the medical center, presented his findings, "A Novel Application of a Full Human Simulator: Training Users of a Newly Introduced Drug (Remifentanil) Prior to Human Use," this week at the annual American Society of Anesthesiologists meeting in Orlando, Fla.

"Being able to present these potent side effects and different scenarios is very valuable. We liken this to flight simulation. There is no substitute for experience," says Murray. He believes patient simulation is an excellent way of introducing new drugs to the medical community.
-end-


Penn State

Related Heart Rate Articles from Brightsurf:

Women veterans with PTSD have higher rate of heart disease
Women veterans with posttraumatic stress disorder (PTSD) were 44% more likely to develop ischemic heart disease including heart attacks, compared to those without PTSD.

Flu vaccine rate less than 25% in young adults with heart disease, despite increased risk
In 2018, only about 25% of adults between the ages of 18 and 34 with any cardiovascular disease received a flu shot, and in those with a history of a heart attack, only about 20% were vaccinated.

Depression risk detected by measuring heart rate changes
For the first time doctors have shown that measuring changes in 24-hour heart rate can reliably indicate whether or not someone is depressed.

Death rate dramatically less for young heart attack survivors who quit smoking
Among young people who have had a heart attack, quitting smoking is associated with a substantial benefit.

Say no to vaping: Blood pressure, heart rate rises in healthy, young nonsmokers
New research finds that nicotine-filled e-cigarettes cause increases in heart rate and blood pressure in young people, health issues that remain even after a vaping session.

Heart rate measurements of wearable monitors vary by activity, not skin color
Biomedical engineers at Duke University have demonstrated that while different wearable technologies, like smart watches and fitness trackers, can accurately measure heart rate across a variety of skin tones, the accuracy between devices begins to vary wildly when they measure heart rate during different types of everyday activities, like typing.

Researchers report first recording of a blue whale's heart rate
With a lot of ingenuity and a little luck, researchers monitored the heart rate of a blue whale in the wild.

Pupil dilation and heart rate, analyzed by AI, may help spot autism early
Autism and other neurodevelopmental disorders often aren't diagnosed until a child is a few years of age, when behavioral interventions and speech/occupational therapy become less effective.

Heart rate variation due to stress affects auditory attention
Study shows that brain activity related to auditory perception parallels heart rate, offering new perspectives for the treatment of attention and communication disorders.

In HIE, lower heart rate variability signals stressed newborns
In newborns with hypoxic-ischemic encephalopathy, lower heart rate variability correlates with autonomic manifestations of stress shortly after birth, underscoring the importance of this reading as a valuable biomarker, according to Children's research presented during the Pediatric Academic Societies 2019 Annual Meeting.

Read More: Heart Rate News and Heart Rate Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.